Close
ACHEMA MIDDLE EAST 2026

INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), a Coronavirus Disease

INOVIO, a biotechnology company bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today...

GSK and Vir Biotechnology Announce Joint Procurement Agreement with European Commission for COVID-19 Treatment

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced they have signed a Joint Procurement Agreement with the European Commission to supply up to 220,000 doses...

CytoSMART introduces new, label-free live-cell microscopy solutions with high image quality

CytoSMART Technologies announced the launch of the new brightfield live-cell imaging system – the CytoSMART Lux3 BR. It is a small brightfield microscope, equipped...

Envirotainer Welcomes China Southern Airlines as the first mainland China carrier to approve the Releye RLP

Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, announced that China Southern Airlines has approved the Envirotainer...

ACG Films and Foils and Danapak Flexibles A/S enters Strategic Partnership for India

ACG, one of world’s most integrated pharmaceutical supplier, announced its strategic partnership with Danapak Flexibles A/S, the global market leader in packaging for high...

Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation

Eli Lilly and Company and Incyte announced results from an additional cohort of 101 adult patients from the COV-BARRIER trial. In this sub-study, patients...

Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule Medicines for Obesity

Regeneron Pharmaceuticals, Inc. and AstraZeneca announced that the companies have entered into a collaboration to research, develop and commercialize small molecule compounds directed against...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...